Objective: To evaluate the pattern of the pulsatile secretion of testosterone in normal menstrual cycle. Methods: Eight healthy women with ovulatory menstrual cycles were enrolled. Blood samples were collected at ten-minute intervals for six hours, starting between 7 and 8 am, after a ten-hour fasting, in three phases: mid-follicular (Day 7), late follicular (Day 12) and mid-luteal phase (Day 21). Samples were assayed for testosterone, LH and the baseline also for SHBG. Results: Testosterone pulse frequency, mean amplitude pulse, percentage of increment in pulse amplitude, mean duration of pulses and pulse interval were similar in the three phases. LH pulsatility was statistically different among the three phases (p < 0.001) representing normal ovulatory cycles. Conclusions: These data increase the knowledge about the testosterone secretion profile in the human menstrual cycle and can be used as a contribution to clinical investigation in both hyperandrogenism and androgen insufficiency syndrome. Arq Bras Endocrinol Metab. 2009;53(8):1040-6 Keywords Testosterone; pulse; menstrual cycle RESUMO Objetivo: Avaliar o padrão pulsátil da secreção da testosterona em mulheres normais. Méto-dos: Oito mulheres saudáveis com ciclos ovulatórios foram selecionadas. Amostras sanguí-neas foram coletadas a cada dez minutos durante seis horas, começando entre 7 e 8 h da manhã, após dez horas de jejum, nas três fases do ciclo menstrual: folicular média (Dia 7), folicular tardia (Dia 12) e lútea (Dia 21). Foram mensurados: testosterona, LH e, no basal, também SHBG. Resultados: A frequência dos pulsos de testosterona, média da amplitude do pulso, porcentagem do incremento da amplitude, duração e intervalos dos pulsos foram similares nas três fases (p > 0,05). A pulsatilidade do LH foi estatisticamente diferente entre as três fases (p < 0,001), caracterizando padrão característico do ciclo ovulatório normal. Conclusões: Esses dados aumentam o conhecimento sobre o padrão de secreção da testosterona no ciclo menstrual humano e representam uma contribuição para a investigação clínica, tanto no hiperandrogenismo como na síndrome de insuficiência androgênica. Arq Bras Endocrinol Metab. 2009;53(8):1040-6 
menstrual cycle. The hormone synthesis depends on several factors, such as gonadotrophin levels and its receptors, level of precursor substrate for steroidogenesis and presence of specific enzymes (1, 2) . An essential factor for this regulation is the pulsatile pattern of gonadotrophin secretion by pituitary (3, 4) .
Androgen synthesis by the ovaries occurs at the theca cells, and is mainly regulated by LH (5, 6) , but also by insulin (7, 8) . These androgens are transferred to the preovulatory granulosa cells, where the androstenedione and testosterone are aromatized to estrone and estradiol by 17-b-hydroxysteroid dehydrogenase type I, stimulated by FSH (9) . The ovarian androgen production and its conversion to estradiol are essential to the physiologic ovulatory process, and an insufficient androgen production at the follicular phase can lead to anovulation (10) .
Some studies have shown fasting testosterone and androstenedione present some fluctuation in menstrual cycle with higher levels in follicular phase than in luteal phase, especially if cycles are ovulatory (11, 12) . The majority of the hormones is synthesized and secreted in a pulsatile pattern. A pulse is identified by an abrupt increase with a subsequent decrease in the hormone output, which reflects in its serum concentration (13) . Although normal pulsatility of androgen secretion was demonstrated in men (14, 15) as well as in some diseases (16) , the normal pulsatile pattern of secretion and its variability among the different phases of the menstrual cycle have not been established yet.
An adequate androgen secretion is important to the follicle recruitment and selection but high androgenic levels can lead to anovulation (17) with changes in the pattern of secretion of gonadotrophins (18) . Barontini and cols. (19) and Veldhuis and cols. (20) have suggested mechanism for pathogenesis of chronic anovulation and have shown disruption of the synchronous secretion of LH and testosterone in adolescents with polycystic ovary syndrome. Considering the related data and the actual facilities in prescribing testosterone for women by gynecologists, it is important to know if there is any variation of this hormone secretion on distinct phases of the normal menstrual cycle, enhancing the knowledge of the woman physiology. Thus, the aim of this study was to analyze the pulsatile secretion profile of testosterone in different phases of ovulatory menstrual cycle in healthy women.
METhODS
Eight young, healthy voluntary women were enrolled in this study. They were required to be between 18 and 30 years-old, non-smokers and with menstrual cycles occurring at regular intervals of 26 to 32 days. Menstrual cycles were considered as regular by menstrual recordings. The first day of menstrual bleeding was considered as the first day of the cycle. Ovulation was confirmed by serum progesterone level performed in the luteal phase (21 st day of the cycle) above 5.0 ng/mL (21) of each studied cycle. In the 21 st day of menstrual cycle, if progesterone levels were under 5.0 ng/mL, the cycle was considered as anovulatory and discharged. Volunteers with history or evidence of heart, liver, or kidney disease, diabetes, menstrual or thyroid disorders, pregnancy, lactation and hypothalamic, pituitary or ovarian disorders were excluded. All patients who were on any drugs which could influence menstrual cycle during last three months were also excluded. The protocol of this experiment was approved by the Institutional Ethics Committee (UFRN), and all participants signed consent forms and received a full verbal and written description of the nature of the experiment, its risks and benefits and their ability to withdraw from the experiment at any time.
Volunteers were screened through interviews, and a clinical examination by a physician was performed before inclusion in the study. Body mass index (BMI) was calculated as weight (kg) divided by the squared height (m 2 ) (22) . All women were kept on dietary and exercise previous habits as well as used a barrier contraception method (condom) during the period of the study.
Experimental data collection
Considering the first day of menstrual cycle as Day 1, blood samples were collected in three phases: mid-follicular (7 th day of the cycle or Day 7), late follicular (Day 12) and mid-luteal phase (Day 21). Blood samples were collected in three consecutive cycles for each subject and hematocrits above 35% were required.
Blood samples were collected via a venous catheter at ten-minute intervals for six hours, starting between 7 and 8 am, after a ten-hour of fasting (n = 37 points/subject). The subjects remained resting during the time of the experiment and were permitted to drink water or juice and to eat fruits at least every two hours. Blood sample were centrifuged and sera were stored at -20 °C until assayed.
hormone assays
Samples collected at ten-minute intervals were assayed for testosterone and LH, and the first sample (baseline) was also assayed for SHBG. Total testosterone determination was performed by radioimmunoassay (RIA), with a "coat-a-count" kit (Diagnostic Products Corporation, Los Angeles, CA, USA), and LH and SHBG levels were performed with chemoluminescent kits at Immullite ® 2000 equipment (Diagnostic Products Corporation, Los Angeles, CA, USA).
Method sensitivities for LH, testosterone and SHBG were 0.05 mUI/mL, 4 ng/dL, and 0.02 nmol/L, respectively. Samples for each subject were done at the same assay to minimize the interassay variation. The intra-assay coefficients of variation for these assays were 3.8% for the LH, 4.8% for testosterone, and 4.2% for SHBG.
Free androgen index (FAI) was calculated from total testosterone and SHBG: FAI = (100 x testosterone)/SHBG with both expressed in nanomoles per liter. FAI results were analyzed in the different phases of menstrual cycle. LH pulsatility was studied to confirm normal pattern of the studied cycles.
Data analysis
The time series of testosterone and LH concentrations over six hours were analyzed for mean concentration, pulse frequency, pulse amplitude, mean % amplitude elevation and pulse duration by the computer program Cluster, developed by Veldhuis and Johnson in 1986 at the University of Virginia. A 2x1 pulse configuration was used with up and down T-ratios of 2 to give a false detection rate less than 10%.
Statistical analysis
Descriptive analysis was performed using GraphPad Prism, version 3.00 for Windows (GraphPad Software, San Diego, CA, USA). All data sets were tested for non-normality. One-way ANOVA and Kruskal-Wallis tests were performed to compare the three phases of menstrual cycle. P-value less than 0.05 was considered statistically significant. Table 1 presents the characteristics of the subjects at the initial evaluation. Mean BMI was 21.33 ± 0.97 kg/m 2 and all volunteers had ovulatory menstrual cycles.
RESUlTS
Mean serum values of testosterone, LH, SHBG and FAI are shown in table 2. There was no statistically significant difference in these parameters among the three menstrual cycle phases evaluated.
LH pulsatility was statistically different among the three phases of the menstrual cycle (p < 0.001) with mean pulse frequency of 4.5 ± 1.51 in mid-follicular phase, 5.125 ± 1.35 in late follicular phase and 1.0 ± 0.75 in luteal phase (Day 21) (Figure 1 ). Mean pulse interval was 66.39 ± 15.19 in mid-follicular phase, 60.00 ± 17.43 in late follicular phase and 100.00 ± 102.50 in the luteal phase (p = 0.02). There was no difference among the three phases in LH mean amplitude pulse, percentage of increment in pulse amplitude and mean duration of pulses (Figure 1) . Figure 2 illustrates serum testosterone pulsatile secretion profile in one of the eight ovulatory women, each of whom underwent repetitive blood sampling at ten-minute intervals in the mid-follicular (Day 7), late follicular (Day 12) and mid-luteal (Day 21) phase of menstrual cycle. Testosterone pulse frequency was similar in the three phases, with a mean of 5.25 ± 0.70 in the mid-follicular phase, 5.0 ± 0.92 in late follicular phase and 6.12 ± 1.45 in the luteal phase (p > 0.05) (Figure 3 ). There was also no difference among the three phases in testosterone mean amplitude pulse, percentage of increment in pulse amplitude and mean duration of pulses (Figure 3 ). Mean frequency of testosterone nadir was 5.25 in the mid-follicular phase, 6.0 in late follicular phase and 6.25 in the luteal phase (p > 0.05). There was no difference in pulse interval and in nadir duration among the three phases (p > 0.05).
DISCUSSIOn
Ovarian function involves hormonal secretion, but also gametogenesis and ovulation. For this, a complex hormonal secretion and a coordinated relationship among Testosterone pulsatility hypothalamus, pituitary and ovary are necessary. The steroidal ovary production is also involved in this process.
Gonadotrophins have different pattern of secretion in men and women since the first day of life (23) . Nevertheless, this difference remains in reproductive life with stable frequency and amplitude in men (24, 25) , but shows great variability in women (26, 27) , including ethnic variations (28) . This gonadotrophin pulsatile liberation reflects the influence of the ovarian steroidal secretion on the hypothalamus pituitary axis.
Androgens are crucial factors for normal development of female gonadal function (10) . There are sufficient data about gonadotrophin pulsatility (27, 29, 30) , but much less is seen about testosterone in the literature. In the present study, LH did show different pulse frequency from the studied phases as already registered by other authors (26, 27) .
Healthy young females with ovulatory cycles have already been studied to evaluate testosterone pulsatility during the menstrual cycle. Multiple samples from each patient were collected: 111 samples, 37 in three menstrual cycles. There was no difference among the three phases in baseline testosterone nor in SHBG. ne (31) , but it also did not show significant difference among the three phases. By using adequate methodology, it has been shown that testosterone, as other hormones involved with reproductive physiology (27) , is secreted in a pulsatile pattern. However, testosterone pulsatility pattern does not vary among the three different menstrual cycle phases studied: mid-follicular, late follicular and luteal phase. It should be considered that, during the reproductive years, androgens are produced by two sources: ovaries and adrenal glands (32) , and these are not under LH control. In addition, other hormones from ovary and adrenal, which production can vary during menstrual cycle, can influence in different ways the activated enzymatic mechanisms of the follicle and luteolysed cells and so could influence testosterone production beyond the LH (2) . Pulsatility studies are usually related to considerable difficulty in volunteer's recruitment. Multiple samples are required and total blood loss is a constant preoccupation (20, 33) . The assay limitation is also important as testosterone assays are designed for higher levels presented in men and could not be accurate enough to determine lower women levels (31, 32) . In addition, serum androgen levels do not necessarily reproduce intraovarian androgen concentrations. Further studies with assisted reproduction techniques could evaluate the correlation between intraovarian androgens and its serum pulsatility.
Variations in androgen levels or in its pulsatility could contribute to the understanding and management of some conditions related to androgen action, such as women mood and sexual behavior in the controversial androgen insufficiency syndrome which was characterized by a team of investigators in 2002 (34) . It is well known that testosterone influence behavior and both cognitive and sexual function in men (35) . However, evidence in women is limited by lack of normative data for androgen levels and much controversy relies about types of treatment. As sexual nor mood questionnaires were not used, comparison between androgen secretion pattern and possible behavior changes in menstrual cycle was not available.
It was shown that there is no variation in testosterone pulsatility during the normal menstrual cycle. This physiologic testosterone pulsatility could be compared to women with clinical features of the androgen insufficiency syndrome even if baseline androgen levels are still normal. Otherwise, testosterone normal pulsatility can also be compared to some hyperandrogenic states as the polycystic ovarian syndrome (PCOS). Peripheral conversion of androgen precursors to active androgens may play an important role in androgen action and this should influence states of hyperandrogenic diseases. It is shown that elevated androgen levels are associated with hyperandrogenic features, as acne and hirsutism, but there is no evidence to support a relationship between the degree of androgen elevation and the severity of these clinical presentations (36) . Sometimes, there is considerable discrepancy between androgen baseline levels and clinical presentation. Expression of androgens receptors in effector organs and hypersensibility of end-target organs are usually considered in these cases, but variations in testosterone pulsatility could explain women presented with hyperandrogenic features and normal baseline androgens.
In conclusion, this study presented, for the first time, that testosterone is secreted in a pulsatile pattern as well as the comparison of this pulsatile profile in distinct phases of the menstrual cycle without differences among them. Additional studies are needed to compare normal ovulatory cycles and pathologic cycles, both in androgen excess and androgen insufficiency, to define if there is any alteration in this pulsatile pattern related to hyperandrogenic anovulation or female androgen insufficiency syndrome.
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